University of Michigan Health System

Oncology & Cancer

Research explains limits of cancer immunotherapy drugs

Immunotherapy treatments have proven wildly successful in treating some patients with cancer. But despite this success, the majority of patients do not respond to the treatments.


Cancer cells hijack glucose, alter immune cells

When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer.

Oncology & Cancer

Avastin, Sutent increase breast cancer stem cells, study shows

Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs don't lead to longer survival, ...

page 3 from 40